COMMUNIQUÉS West-GlobeNewswire

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/05/2026
BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that [...]
Korro to Participate in Upcoming Investor Conferences
05/05/2026
CAMBRIDGE, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Korro, Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company leveraging a novel oligonucleotide promoted editing of RNA (OPERA®) platform to develop a new class [...]
InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2026
05/05/2026
DENVER, May 05, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible [...]
LeMaitre Q1 2026 Financial Results
05/05/2026
BURLINGTON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2026 results, announced a quarterly dividend of $0.25 [...]
Pacira BioSciences Mails Letter to Stockholders
05/05/2026
Details Success of Pacira’s 5x30 Strategy and Solid First Quarter 2026 Results Reiterates Board’s Unanimous Recommendation that Stockholders Vote “FOR” the Election of Pacira’s Highly Qualified Nominees on the BLUE [...]
Iridex to Report First Quarter 2026 Financial Results on May 19, 2026
05/05/2026
MOUNTAIN VIEW, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the [...]
Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
05/05/2026
BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today [...]
Carlsmed® Reports First Quarter 2026 Financial Results
05/05/2026
First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year Full year 2026 revenue guidance raised to $72 million to $77 million CARLSBAD, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc [...]
Longeveron to Report 2026 First Quarter Financial Results and Host Conference Call on May 13, 2026
05/05/2026
MIAMI, May 05, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today [...]
Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference
05/05/2026
SEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation [...]
Ligand to Participate in May Investor Conferences
05/05/2026
JUPITER, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its senior management team will participate in the following upcoming investor conferences: H.C. [...]
Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026
05/05/2026
LAKEWOOD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ended March 31, 2026 at approximately [...]
Neuvasq Presents Data Showcasing Promising Novel Multispecific Gpr124-Targeting Antibodies for Blood Retina Barrier Restoration at ARVO 2026
05/05/2026
Gosselies, Belgium, May 05, 2026 (GLOBE NEWSWIRE) -- Gpr124 represents a promising novel target for improving the integrity and function of the blood-retina barrier (BRB) with the goal of slowing, halting, preventing or [...]
The Association of American Physicians and Surgeons Files in the U.S. Supreme Court in Opposition to Mifepristone Abortion-by-Mail
05/05/2026
TUCSON, Ariz., May 05, 2026 (GLOBE NEWSWIRE) -- A momentous abortion issue is suddenly before the U.S. Supreme Court. Two makers of mifepristone, the drug that induces a chemical abortion, immediately petitioned the U.S [...]
SK pharmteco obtient la validation de la SBTi pour ses objectifs scientifiques de neutralité carbone à horizon 2040
05/05/2026
RANCHO CORDOVA, Californie, 05 mai 2026 (GLOBE NEWSWIRE) -- SK pharmteco annonce ce jour la validation officielle de ses objectifs de réduction des émissions de gaz à effet de serre (GAS) par la Science Based Targets [...]
CORRECTION: GenEmbryomics and Genomic Prediction Launch XGEN PGT-X™
05/05/2026
HACKETTSTOWN, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- CORRECTION NOTICE: The press release issued by GenEmbryomics Limited on 30 April 2026, titled “GenEmbryomics and Genomic Prediction Launch XGEN PGT-X™ - Embryo Genome [...]
NTG Nordic Transport Group A/S invites to Capital Markets Day on November 18, 2026
05/05/2026
NTG Nordic Transport Group – Capital Markets Day 2026 We would like to invite institutional investors and analysts to attend our Capital Markets Day on 18 November 2026. A detailed programme will follow, but please mark [...]
Atos and CNA strengthen long-term strategic partnership through new multi-year infrastructure services agreement
05/05/2026
Irving, Texas, USA – May 5, 2026 – Atos , a global leader in AI-powered digital transformation, today announced the extension and expansion of its long-standing strategic partnership with CNA, one of the largest U.S. [...]
NTG Nordic Transport Group publishes interim report for Q1 2026
05/05/2026
Company announcement no. 14 – 26 05 May 2026 NTG Nordic Transport Group publishes interim report for Q1 2026 The interim report for Q1 2026 is enclosed. In connection with publication of the results for Q1 2026, a [...]

Pages